The pediatric study, in children ages 5 to 11, is the first to disclose results in young children. It used a lower dose of the vaccine than the one currently being administered, because earlier studies showed that the adult dose could cause more side effects. Adults receive two 30 microgram doses of the vaccine three weeks apart. In school-aged children, this was lowered to 10 micrograms.
The Shenaz
Jebet
Vipgame
Cổng Game B52club
Thomas Johnston
Thể Thao Tổng Hợp
Callactive
Nuhealth Md
Kết Quả Bóng Đá
Go8dad1